{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:54:15Z","timestamp":1786992855542,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jlr.2024.100551","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T19:31:44Z","timestamp":1720899104000},"page":"100551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impaired intestinal free fatty acid transport followed by chylomicron malformation, not pancreatic insufficiency, cause metabolic defects in cystic fibrosis"],"prefix":"10.1016","volume":"65","author":[{"given":"Lihong","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-4389","authenticated-orcid":false,"given":"Nikolaos","family":"Dedousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneseh","family":"Adeshirlarijaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra S.","family":"Kanshana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-7283","authenticated-orcid":false,"given":"Alison B.","family":"Kohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100551_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s004180000164","article-title":"Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract","volume":"114","author":"Ameen","year":"2000","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.jlr.2024.100551_bib2","article-title":"CFTR High Expresser Cells in cystic fibrosis and intestinal diseases","volume":"9","author":"Reis","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jlr.2024.100551_bib3","doi-asserted-by":"crossref","first-page":"G453","DOI":"10.1152\/ajpgi.00094.2013","article-title":"Characterization of CFTR high expresser cells in the intestine","volume":"305","author":"Jakab","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib4","doi-asserted-by":"crossref","first-page":"G1241","DOI":"10.1152\/ajpgi.00493.2004","article-title":"Chloride conductance of CFTR facilitates basal Cl -\/HCO 3- exchange in the villous epithelium of intact murine duodenum","volume":"288","author":"Simpson","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175467","article-title":"Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction","volume":"12","author":"Darrah","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100551_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib7","doi-asserted-by":"crossref","first-page":"a009753","DOI":"10.1101\/cshperspect.a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"Lisle","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jlr.2024.100551_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nut.2015.10.012","article-title":"Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity","volume":"32","author":"Alvarez","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.jlr.2024.100551_bib9","first-page":"408","article-title":"Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients","volume":"5","author":"Gibson","year":"1986","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clnu.2012.08.017","article-title":"Stunting is an independent predictor of mortality in patients with cystic fibrosis","volume":"32","author":"Vieni","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100551_bib12","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/nu13092907","article-title":"The impact of highly effective cftr modulators on growth and nutrition status","volume":"13","author":"Bass","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jlr.2024.100551_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2019.04.001","article-title":"Cystic fibrosis dyslipidaemia: a cross-sectional study","volume":"18","author":"Nowak","year":"2019","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib14","article-title":"Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: a randomized controlled trial","volume":"15","author":"Stallings","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100551_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ppul.20619","article-title":"Predictors of mortality in adults with cystic fibrosis","volume":"42","author":"Courtney","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jlr.2024.100551_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcf.2015.01.006","article-title":"Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation","volume":"14","author":"Bodewes","year":"2015","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/23808993.2016.1175299","article-title":"Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation","volume":"1","author":"Cholon","year":"2016","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"key":"10.1016\/j.jlr.2024.100551_bib18","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/ppul.23528","article-title":"Gastroenterological endpoints in drug trials for cystic fibrosis","volume":"51","author":"Bodewes","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jlr.2024.100551_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-023-02451-0","article-title":"Heterogeneity of weight gain after initiation of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis","volume":"24","author":"Gramegna","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.jlr.2024.100551_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009746","article-title":"The cystic fibrosis of exocrine pancreas","volume":"3","author":"Wilschanski","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jlr.2024.100551_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-017-0783-y","article-title":"Practical guide to exocrine pancreatic insufficiency \u2013 Breaking the myths","volume":"15","author":"Struyvenberg","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.jlr.2024.100551_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcf.2011.03.008","article-title":"Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice","volume":"10","author":"Wouthuyzen-Bakker","year":"2011","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib23","doi-asserted-by":"crossref","first-page":"G646","DOI":"10.1152\/ajpgi.00295.2004","article-title":"Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events","volume":"288","author":"Bijvelds","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MPG.0b013e3181b18308","article-title":"Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric\/behenic acid","volume":"50","author":"Dorsey","year":"2010","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/0884533615591604","article-title":"Nutrition management of cystic fibrosis in the 21st Century","volume":"30","author":"Schindler","year":"2015","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.jlr.2024.100551_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/DDDT.S9258","article-title":"Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies","volume":"6","author":"Wilschanski","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jlr.2024.100551_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1203\/PDR.0b013e3181b4e8d3","article-title":"Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy","volume":"66","author":"Aldamiz-Echevarria","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jlr.2024.100551_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0000000000000272","article-title":"Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention","volume":"58","author":"Bertolaso","year":"2014","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0300-9084(88)90193-9","article-title":"Isolation of the early phase of chylomicron formation in intestinal epithelial cells of rats","volume":"70","author":"Turner","year":"1988","journal-title":"Biochimie"},{"key":"10.1016\/j.jlr.2024.100551_bib30","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1194\/jlr.M017418","article-title":"Impact of murine intestinal apolipoprotein A-IV expression on regional lipid absorption, gene expression, and growth","volume":"52","author":"Simon","year":"2011","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib31","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/S0022-2275(20)37472-1","article-title":"Effects of particle size and number on the plasma clearance of chylomicrons and remnants","volume":"37","author":"Martins","year":"1996","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib32","doi-asserted-by":"crossref","first-page":"G628","DOI":"10.1152\/ajpgi.00225.2011","article-title":"Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function","volume":"302","author":"Kohan","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib33","doi-asserted-by":"crossref","first-page":"G1128","DOI":"10.1152\/ajpgi.00409.2012","article-title":"Is apolipoprotein A-IV rate limiting in the intestinal transport and absorption of triglyceride?","volume":"304","author":"Kohan","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/phy2.247","article-title":"Overexpression of apolipoprotein C-III decreases secretion of dietary triglyceride into lymph","volume":"2","author":"Wang","year":"2014","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.jlr.2024.100551_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1194\/jlr.M092460","article-title":"Intestinal basolateral lipid substrate transport is linked to chylomicron secretion and is regulated by apoC-III","volume":"60","author":"Li","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib36","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s00125-017-4401-5","article-title":"VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells","volume":"60","author":"Botteri","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jlr.2024.100551_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100284","article-title":"A\u00a0single-day mouse mesenteric lymph surgery in mice: an updated approach to study dietary lipid absorption, chylomicron secretion, and lymphocyte dynamics","volume":"63","author":"Dedousis","year":"2022","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib38","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1111\/j.1749-6632.2010.05753.x","article-title":"Lymphatics in intestinal transport of nutrients and gastrointestinal hormones","volume":"1207","author":"Kohan","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jlr.2024.100551_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-2275(20)39442-6","article-title":"Fat transport and lymph and plasma lipoprotein biosynthesis by isolated intestine","volume":"13","author":"Windmueller","year":"1972","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib40","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1016\/S0021-9258(18)50321-5","article-title":"Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat","volume":"254","author":"Wu","year":"1979","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100551_bib41","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/S0022-2275(20)39201-4","article-title":"Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons","volume":"36","author":"Hultin","year":"1995","journal-title":"J.\u00a0lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00383-020-04802-0","article-title":"What is the optimal lipid emulsion for preventing intestinal failure-associated liver disease following parenteral feeding in a rat model of short-bowel syndrome?","volume":"37","author":"Machigashira","year":"2021","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.jlr.2024.100551_bib43","first-page":"R1170","article-title":"Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats","volume":"272","author":"Rodriguez","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib44","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jpen.1850","article-title":"Evaluation of SMOFlipid in pediatric intestinal-failure patients and its effects on essential fatty acid levels","volume":"45","author":"Ho","year":"2021","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jpen.2003","article-title":"Reversal of intestinal failure\u2013associated liver disease in an infant treated with mixed lipid emulsion and multidisciplinary intestinal rehabilitation program","volume":"45","author":"Molinos","year":"2021","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib46","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1111\/j.1749-6632.2010.05713.x","article-title":"Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction","volume":"1207","author":"Deitch","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jlr.2024.100551_bib47","first-page":"620","article-title":"External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph","volume":"40","author":"Jensen","year":"1990","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.jlr.2024.100551_bib48","doi-asserted-by":"crossref","DOI":"10.3791\/64338-v","article-title":"The isolation of flowing mesenteric lymph in mice to quantify In\u00a0Vivo kinetics of dietary lipid absorption and chylomicron secretion","author":"Dedousis","year":"2022","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.jlr.2024.100551_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2004.04.007","article-title":"A\u00a0novel, noninvasive method for the measurement of intestinal fat absorption","volume":"127","author":"Jandacek","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2024.100551_bib50","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M071340","article-title":"Using murine-derived primary intestinal enteroids for studies of dietary triglyceride absorption and lipoprotein synthesis, and to determine the role of intestine-specific apoC-III","volume":"58","author":"Jattan","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A\u00a0simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100551_bib52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/dvg.20433","article-title":"Generation of a conditional null allele for Cftr in mice","volume":"46","author":"Hodges","year":"2008","journal-title":"Genesis"},{"key":"10.1016\/j.jlr.2024.100551_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0199573","article-title":"A\u00a0G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies","volume":"13","author":"McHugh","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100551_bib54","doi-asserted-by":"crossref","first-page":"G528","DOI":"10.1152\/ajpgi.00052.2011","article-title":"Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium","volume":"301","author":"Hodges","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10030483","article-title":"Cftr modulator therapy with lumacaftor\/ivacaftor alters plasma concentrations of lipid-soluble vitamins a and e in patients with cystic fibrosis","volume":"10","author":"Sommerburg","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jlr.2024.100551_bib56","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jcf.2020.06.015","article-title":"Lumacaftor\/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis","volume":"20","author":"Gelzo","year":"2021","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib57","first-page":"47","article-title":"Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis","volume":"12","author":"Borowitz","year":"2007","journal-title":"The J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.jlr.2024.100551_bib58","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbalip.2011.09.013","article-title":"Gut triglyceride production","volume":"1821","author":"Pan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2024.100551_bib59","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.celrep.2019.07.030","article-title":"ATGL\/CGI-58-Dependent hydrolysis of a lipid storage Pool in murine enterocytes","volume":"28","author":"Korbelius","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2024.100551_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M031716","article-title":"Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPAR\u03b1 signaling","volume":"54","author":"Obrowsky","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib61","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/jum.15001","article-title":"Evaluation of gastric emptying in cystic fibrosis using Bedside Ultrasonography","volume":"38","author":"Nazareth","year":"2019","journal-title":"J.\u00a0Ultrasound Med."},{"key":"10.1016\/j.jlr.2024.100551_bib62","doi-asserted-by":"crossref","first-page":"G104","DOI":"10.1152\/ajpgi.00548.2006","article-title":"Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine","volume":"293","author":"Lisle","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1113\/jphysiol.1967.sp008210","article-title":"The effect of a non-ionic detergent (Triton WR 1339) on the removal of triglyceride fatty acids from the blood of the rat","volume":"190","author":"Otway","year":"1967","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1113\/jphysiol.1967.sp008211","article-title":"The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions","volume":"190","author":"Otway","year":"1967","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib65","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0021-9150(98)00215-9","article-title":"Kinetics of triglyceride rich lipoproteins: chylomicrons and very low density lipoproteins","volume":"141","author":"Hugh","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2024.100551_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0007114598001585","article-title":"Lipoprotein lipase and the disposition of dietary fatty acids","volume":"80","author":"Fielding","year":"1998","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib67","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/S0021-9258(19)39557-2","article-title":"Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV","volume":"265","author":"Goldberg","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100551_bib68","first-page":"H1283","article-title":"Distribution, propagation, and coordination of contractile activity in lymphatics","volume":"264","author":"Zawieja","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib69","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2020.00458","article-title":"Intestinal lymph flow, and lipid and drug transport Scale Allometrically from pre-clinical species to humans","volume":"11","author":"Trevaskis","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib70","first-page":"G21","article-title":"Role of lymph flow in intestinal chylomicron transport","volume":"249","author":"Tso","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-physiol-021909-135801","article-title":"The Biogenesis of chylomicrons","volume":"72","author":"Mansbach","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.619442","article-title":"CFTR Correctors and Antioxidants partially normalize lipid Imbalance but not abnormal basal inflammatory Cytokine profile in CF Bronchial epithelial cells","volume":"12","author":"Veltman","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcf.2018.08.009","article-title":"Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis","volume":"18","author":"van de Peppel","year":"2019","journal-title":"J.\u00a0Cystic Fibrosis"},{"key":"10.1016\/j.jlr.2024.100551_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0245302","article-title":"Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study","volume":"16","author":"Amato","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100551_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MED.0000000000000136","article-title":"Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease","volume":"22","author":"Kohan","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.jlr.2024.100551_bib76","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-2275(20)40179-8","article-title":"Influence of bile Salt, Ph, and time on the action of pancreatic lipase; physiological implications","volume":"5","author":"Borgstroem","year":"1964","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100551_bib77","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1139\/y93-078","article-title":"Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond","volume":"71","author":"Thomson","year":"1993","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100551_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/7651_2017_69","article-title":"The isolation, culture, and propagation of murine intestinal enteroids for the study of dietary lipid metabolism","volume":"1576","author":"Li","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jlr.2024.100551_bib79","doi-asserted-by":"crossref","first-page":"G282","DOI":"10.1152\/ajpgi.00290.2021","article-title":"Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine","volume":"322","author":"Walker","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib80","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1007\/s00018-021-04014-2","article-title":"Role for animal models in understanding essential fatty acid deficiency in cystic fibrosis","volume":"78","author":"Hryciw","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jlr.2024.100551_bib81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1165\/rcmb.2013-0261OC","article-title":"Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets","volume":"50","author":"Sun","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jlr.2024.100551_bib82","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jlr.2024.100551_bib83","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/ajcn\/70.5.943a","article-title":"Fat malabsorption in cystic fibrosis patients [4] (multiple letters)","volume":"70","author":"Murphy","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/adc.66.4.495","article-title":"Energy content of stools in normal healthy controls and patients with cystic fibrosis","volume":"66","author":"Murphy","year":"1991","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jlr.2024.100551_bib85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/09638289809166733","article-title":"Nutritional management in cystic fibrosis \u2014 an alternative perspective in gastrointestinal function","volume":"20","author":"Murphy","year":"1998","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.jlr.2024.100551_bib86","doi-asserted-by":"crossref","first-page":"G1239","DOI":"10.1152\/ajpgi.00206.2009","article-title":"CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2\/15 cells","volume":"297","author":"Mailhot","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/f9b8a9d2-4be3-4981-92f4-a3b4cb0b0bf5","article-title":"CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2\/15 cells","volume":"5","author":"Mailhot","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100551_bib88","doi-asserted-by":"crossref","first-page":"G82","DOI":"10.1152\/ajpgi.00245.2010","article-title":"Physiological relevance of cell-specific distribution patterns of CFTR, NKCC1, NBCe1, and NHE3 along the crypt-villus axis in the intestine","volume":"300","author":"Jakab","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib89","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jcmgh.2022.02.007","article-title":"A\u00a0proximal-to-distal survey of healthy adult human small intestine and colon epithelium by single-cell transcriptomics","volume":"13","author":"Burclaff","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2024.100551_bib90","doi-asserted-by":"crossref","first-page":"G222","DOI":"10.1152\/ajpgi.00405.2006","article-title":"Intestinal phenotype of variable-weight cystic fibrosis knockout mice","volume":"293","author":"Canale-Zambrano","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jlr.2024.100551_bib91","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1038\/s41598-022-10328-3","article-title":"Alterations of mucosa-attached microbiome and epithelial cell numbers in the cystic fibrosis small intestine with implications for intestinal disease","volume":"12","author":"Kelly","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100551_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112249","article-title":"MFGE8 links absorption of dietary fatty acids with catabolism of enterocyte lipid stores through HNF4\u03b3-dependent transcription of CES enzymes","volume":"42","author":"Datta","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jlr.2024.100551_bib93","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0005-2760(66)90019-1","article-title":"Heterogeneity in the rate of plasma clearance of chylomicrons of different size","volume":"116","author":"Quarfordt","year":"1966","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2024.100551_bib94","doi-asserted-by":"crossref","first-page":"31348","DOI":"10.1074\/jbc.272.50.31348","article-title":"Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor","volume":"272","author":"Mann","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100551_bib95","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/MPG.0000000000001004","article-title":"Choline supplementation with a structured lipid in children with cystic fibrosis: a randomized placebo-controlled trial","volume":"62","author":"Schall","year":"2016","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib96","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcf.2011.10.007","article-title":"A\u00a0fat lot of good: balance and trends in fat intake in children with cystic fibrosis","volume":"11","author":"Smith","year":"2012","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib97","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3390\/nu12103126","article-title":"Adherence to dietary recommendations, nutrient intake adequacy and diet quality among pediatric cystic fibrosis patients: results from the greecf study","volume":"12","author":"Poulimeneas","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jlr.2024.100551_bib98","article-title":"Dosing regimens for pancreatic enzyme replacement therapy (PERT) in cystic fibrosis","volume":"2019","author":"Ng","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jlr.2024.100551_bib99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/adc.44.235.401","article-title":"Assessment of medium-chain triglyceride feeding in infants with cystic fibrosis","volume":"44","author":"Gracey","year":"1969","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jlr.2024.100551_bib100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0148607197021005275","article-title":"Determination of the route of medium-chain and long-chain fatty acid absorption by direct measurement in the rat","volume":"21","author":"Sigalet","year":"1997","journal-title":"J.\u00a0Parenter. Enteral Nutr."},{"key":"10.1016\/j.jlr.2024.100551_bib101","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: report of promise-GI","volume":"22","author":"Schwarzenberg","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib102","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","article-title":"PROMISE: working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy","volume":"20","author":"Nichols","year":"2021","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jlr.2024.100551_bib103","doi-asserted-by":"crossref","first-page":"877118","DOI":"10.3389\/fphar.2022.877118","article-title":"Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score","volume":"13","author":"Mainz","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T19:13:28Z","timestamp":1728414808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0022227524000567"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100551","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired intestinal free fatty acid transport followed by chylomicron malformation, not pancreatic insufficiency, cause metabolic defects in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100551"}}